Smart insulin pen is a medical device used to inject insulin for the treatment of diabetes. Insulin pens have an attached insulin cartridge and hence do not need a syringe and separate vial.... Research Beam Model: Research Beam Product ID: 2105060 5370 USD New
Smart Insulin Pens Market by Type (First Generation Pens and Second Generation Pens), by Usability (Pre-filled and Reusable), and by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Home Care Settings) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Smart Insulin Pens Market by Type (First Generation Pens and Second Generation Pens), by Usability (Pre-filled and Reusable), and by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Home Care Settings) - Global Opportunity Analysis and Industry Forecast, 2017-2023

 
  • Category : Healthcare
  • Published On : August  2017
  • Pages : 120
 
 

Smart insulin pen is a medical device used to inject insulin for the treatment of diabetes. Insulin pens have an attached insulin cartridge and hence do not need a syringe and separate vial.  
The global smart insulin pens market was valued at $57 million in 2016, and is estimated to reach $117 million by 2023, growing at a CAGR of 10.7% from 2017 to 2023. The market is expected to witness significant growth during the forecast period owing to rising geriatric population coupled with increasing incidence of diabetics. In addition, these pens can be easily used by people with visual or fine motor skills impairments further stimulates the market growth. However, insulin pens are inconvenient to use for the patients in need of mixture of two type of insulins, which in turn impedes the market growth.

The global smart insulin pens market is segmented on the basis of type, usability, end user, and region. Based on type, the market is classified into first generation and second generation insulin pens. The second generation insulin pens are further bifurcated into Bluetooth-enabled and USB-connected insulin pens. By usability, it is segmented into pre-filled and reusable insulin pumps. According to the end user, the market is classified into hospitals & clinics, ambulatory surgical centers, and home care settings. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The global smart insulin pens market is highly competitive and is lucrative in nature. The key market players have adopted various developmental strategies such as product launch & approval, strategic acquisitions, and mergers to strengthen their market position.

Key Benefits for Stakeholders

  • The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors.
  •  It offers an extensive analysis of the current and emerging market trends and dynamics through 2016–2023 to identify the upcoming market opportunities.
  • Recent industry trends and developments and the future opportunities are also covered.
  • Extensive knowledge about the key market players and their strategies is provided.
  • Comprehensive analysis of factors that drive and restrain the growth of the market is provided.

Key Market Segments

By Type

  • First Generation Pens
  • Second Generation Pens
    • Bluetooth Enabled
    • USB Connected

By Usability

  • Prefilled
  • Reusable

By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa

Key market players

  • The key players operating in this market include the following:
  • Eli Lilly and Company
  • Novo Nordisk
  • Companion Medical
  • DIAMESCO
  • Emperra GmbH

CHAPTER 1 INTRODUCTION

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top wining strategies

3.2.1.1. Competitive intelligence of companies and their strategies

3.2.2. Top investment pockets

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Increasing incidence of diabetes
3.3.1.2. Rising geriatric population
3.3.1.3. Technological advancements

3.3.2. Restrains

3.3.2.1. Not suitable for combination insulin

3.3.3. Opportunities

3.3.3.1. Untapped opportunities in emerging nations

3.3.4. Impact analysis

3.4. MARKET SHARE ANALYSIS, 2016
3.5. GOVERNMENT REGULATIONS
3.6. CLINICAL TRIALS

CHAPTER 4 SMART INSULIN PENS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. FIRST GENERATION PENS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. SECOND GENERATION PENS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Bluetooth-enabled pens

4.3.4.1. Market size and forecast

4.3.5. USB connected pens

4.3.5.1. Market size and forecast

CHAPTER 5 SMART INSULIN PENS MARKET, BY USABILITY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. PRE-FILLED PENS

5.2.1. Market size and forecast

5.3. REUSABLE PENS

5.3.1. Market size and forecast

CHAPTER 6 SMART INSULIN PENS MARKET, BY END-USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS & CLINICS

6.2.1. Market size and forecast

6.3. AMBULATORY SURGICAL CENTERS

6.3.1. Market size and forecast

6.4. HOME CARE SETTINGS

6.4.1. Market size and forecast

CHAPTER 7 SMART INSULIN PENS MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. India market size and forecast
7.4.3.4. Australia market size and forecast
7.4.3.5. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. South Africa market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. ELI LILLY AND COMPANY

8.1.1. Company overview
8.1.2. Operating business segments
8.1.3. Business performance
8.1.4. Key strategic moves and developments

8.2. NOVO NORDISK

8.2.1. Company overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategic moves and developments

8.3. COMPANION MEDICAL

8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Business performance
8.3.4. Key strategic moves and developments

8.4. DIAMESCO

8.4.1. Company overview
8.4.2. Operating business segments
8.4.3. Business performance
8.4.4. Key strategic moves and developments

8.5. EMPERRA GMBH

8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Business performance
8.5.4. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2. GLOBAL FIRST GENERATION PENS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL FIRST GENERATION PENS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 4. GLOBAL SECOND GENERATION PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 5. GLOBAL SECOND GENERATION PENS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL SECOND GENERATION PENS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 7. GLOBAL SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 8. GLOBAL SMART INSULIN PENS MARKET FOR PRE-FILLED PENS, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL SMART INSULIN PENS MARKET FOR PRE-FILLED PENS, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 10. GLOBAL SMART INSULIN PENS MARKET FOR REUSABLE PENS, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL SMART INSULIN PENS MARKET FOR REUSABLE PENS, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 12. GLOBAL SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 13. GLOBAL SMART INSULIN PENS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL SMART INSULIN PENS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 15. GLOBAL SMART INSULIN PENS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL SMART INSULIN PENS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 17. GLOBAL SMART INSULIN PENS MARKET FOR HOME CARE SETTINGS, BY REGION, 2016-2023 ($MILLION)
TABLE 18. GLOBAL SMART INSULIN PENS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 19. SMART INSULIN PENS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. NORTH AMERICA SMART INSULIN PENS MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 21. NORTH AMERICA SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 22. NORTH AMERICA SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 23. NORTH AMERICA SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 24. U.S. SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 25. U.S. SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 26. U.S. SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 27. CANADA SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 28. CANADA SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 29. CANADA SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 30. MEXICO SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 31. MEXICO SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 32. MEXICO SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 33. EUROPE SMART INSULIN PENS MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 34. EUROPE SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 35. EUROPE SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 36. EUROPE SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 37. GERMANY SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 38. GERMANY SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 39. GERMANY SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 40. FRANCE SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 41. FRANCE SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 42. FRANCE SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 43. UK SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 44. UK SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 45. UK SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 46. ITALY SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 47. ITALY SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 48. ITALY SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 49. SPAIN SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 50. SPAIN SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 51. SPAIN SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 52. REST OF EUROPE SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 53. REST OF EUROPE SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 54. REST OF EUROPE SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 55. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 56. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 57. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 58. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 59. JAPAN SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 60. JAPAN SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 61. JAPAN SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 62. CHINA SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 63. CHINA SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 64. CHINA SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 65. INDIA SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 66. INDIA SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 67. INDIA SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 68. AUSTRALIA SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 69. AUSTRALIA SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 70. AUSTRALIA SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 74. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY COUNTRY 2016-2023 ($MILLION)
TABLE 75. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 76. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 77. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 78. BRAZIL SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 79. BRAZIL SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 80. BRAZIL SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 81. SOUTH AFRICA SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 82. SOUTH AFRICA SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 83. SOUTH AFRICA SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 84. SAUDI ARABIA SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 85. SAUDI ARABIA SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 86. SAUDI ARABIA SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 87. REST OF LAMEA SMART INSULIN PENS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 88. REST OF LAMEA SMART INSULIN PENS MARKET, BY USABILITY, 2016-2023 ($MILLION)
TABLE 89. REST OF LAMEA SMART INSULIN PENS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 90. ELI LILLY AND COMPANY: COMPANY SNAPSHOT
TABLE 91. NOVO NORDISK: COMPANY SNAPSHOT
TABLE 92. COMPANION MEDICAL: COMPANY SNAPSHOT
TABLE 93. DIAMESCO: COMPANY SNAPSHOT
TABLE 94. EMPERA GMBH: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. MARKET SEGMENTATION
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2016)
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. TOP INVESTMENT POCKETS
FIGURE 9. IMPACT ANALYSIS, 2016
FIGURE 10. MARKET SHARE ANALYSIS, 2016
FIGURE 11. BLUETOOTH-ENABLED PENS MARKET, 2016-2023 ($MILLION)
FIGURE 12. USB CONNECTED PENS MARKET, 2016-2023 ($MILLION)